Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk network among multiple inflammatory mediators in liver fibrosis
Hanjing Zhangdi, Si-Biao Su, Fei Wang, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 33, pp. 4835-4849
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 174
Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism
Xingtao Zhao, Jing Wang, Ying Deng, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 4727-4747
Closed Access | Times Cited: 86
Animal and Organoid Models of Liver Fibrosis
Yulong Bao, Li Wang, Haiting Pan, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 76
Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo
Haili Wang, Jin-Ying Che, Kai Cui, et al.
Phytomedicine (2021) Vol. 88, pp. 153609-153609
Closed Access | Times Cited: 61
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma
Hui Li
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 3, pp. 217-233
Closed Access | Times Cited: 59
Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development
Simona-Rebeca Ignat, Sorina Dinescu, Anca Hermenean, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 461-461
Open Access | Times Cited: 50
The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity
Asrin Ahmadi, Hossein Niknahad, Huifeng Li, et al.
Toxicology Letters (2021) Vol. 349, pp. 12-29
Closed Access | Times Cited: 47
Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
Rui Qin, Qian Zhao, Bo Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling
Yimin Sun, Bingyan Liu, Jianping Xie, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 5
Open Access | Times Cited: 28
Ameliorative effect of curcuminoids in liver fibrosis rat model via regulating GIPC1 gene and modulating MMP-8/TIMP-3 balance mediated by miR-483-5p
Rana Adel, Sara Mostafa Kamal, Eman M. Sherif, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2025) Vol. 14, Iss. 1
Open Access
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access
Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages
Jianping Sheng, Baohang Zhang, Yongfeng Chen, et al.
Immunopharmacology and Immunotoxicology (2020) Vol. 42, Iss. 6, pp. 556-563
Closed Access | Times Cited: 32
The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
Ya Yang, Yalei Zhao, Lingjian Zhang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 31
Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, et al.
Pharmacology & Therapeutics (2020) Vol. 222, pp. 107752-107752
Closed Access | Times Cited: 28
Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo
Nazli Khodayari, Regina Oshins, L. Shannon Holliday, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 27
The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
Yijing Ren, Siyue Li, Zixuan Song, et al.
Nutrients (2022) Vol. 14, Iss. 11, pp. 2303-2303
Open Access | Times Cited: 18
Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice
Francesco Suriano, Sara Vieira‐Silva, Gwen Falony, et al.
AJP Endocrinology and Metabolism (2022) Vol. 324, Iss. 1, pp. E85-E96
Open Access | Times Cited: 15
Intravenous Umbilical Cord-derived Mesenchymal Stem Cells Transplantation Regulates Hyaluronic Acid and Interleukin-10 Secretion Producing Low-grade Liver Fibrosis in Experimental Rat
Taufik Sungkar, Agung Putra, Dharma Lindarto, et al.
Medical Archives (2020) Vol. 74, Iss. 3, pp. 177-177
Open Access | Times Cited: 21
Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis
Hui Yang, Juan Wang, Zhenguo Liu
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 10, pp. 2757-2765
Open Access | Times Cited: 12
Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis
Usman Sabir, Hongmei Gu, Dawei Zhang
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4932-4962
Open Access | Times Cited: 7
The Effect of Mesenchymal Stem Cell-Derived Exosomes and miR17-5p Inhibitor on Multicellular Liver Fibrosis Microtissues
Farnaz Sani, Mina Soufi Zomorrod, Negar Azarpira, et al.
Stem Cells International (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 6
Ecballium elaterium improved stimulatory effects of tissue-resident NK cells and ameliorated liver fibrosis in a thioacetamide mice model
Mustafa Ghanim, Johnny Amer, Ahmad Salhab, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112942-112942
Open Access | Times Cited: 9
Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis
Mishghan Zehra, James C Curry, Sneha S. Pillai, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4737-4737
Open Access | Times Cited: 14
A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
Fan Chang, Fu Rong Wu, Jia Fu Zhang, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 13
TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis
Sujie Liu, Juan Wu, Pingping Chen, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top